Delivery Order SPE2DX22D0010-SPE2D826FBR13
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $35,745.68 to AmerisourceBergen Drug Corp on December 11, 2025, with completion scheduled for December 12, 2025. This firm fixed-price, competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The order will be fulfilled at AmerisourceBergen's corporate...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a firm fixed-price delivery order valued at $10,750.82 to AmerisourceBergen Drug Corp on December 8, 2025, with an ultimate completion date of December 9, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 through December 2026. AmerisourceBergen, a major...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $14,257.39 to AmerisourceBergen Drug Corp on December 1, 2025, with an ultimate completion date of December 2, 2025. This firm fixed-price, non-set-aside contract represents a child order issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million and extending through December 2026. The delivery order is being performed at the...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $28,224.74 to AmerisourceBergen Drug Corp on November 24, 2025, with completion scheduled for November 25, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical distributor,...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a firm fixed-price delivery order valued at $17,976.57 to AmerisourceBergen Drug Corp on December 9, 2025, with completion targeted for December 10, 2025. This non-set-aside contract is a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement running through December 2026. The delivery order represents one of numerous...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $66,973.11 to AmerisourceBergen Drug Corp on December 8, 2025, with an ultimate completion date of December 9, 2025. This firm fixed-price, non-set-aside delivery order (Contract No. 4570204693) represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. AmerisourceBergen, a major...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,160.92 to AmerisourceBergen Drug Corp on December 8, 2025, with an ultimate completion date of December 9, 2025. This firm fixed-price, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The order was placed with AmerisourceBergen's Corporate Office division, headquartered in Conshohocken,...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a $14,257.39 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 20, 2025, with completion expected by October 21, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery order is to be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $154,498.40 to AmerisourceBergen Drug Corp on December 8, 2025, with an ultimate completion date of December 9, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at the vendor's...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $369,718.44 to AmerisourceBergen Drug Corp on November 3, 2025, with an ultimate completion date of November 4, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The delivery...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FBR13Delivery Order
The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $122,859.17 to AmerisourceBergen Drug Corp on December 10, 2025, with completion expected by December 11, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The vendor, headquartered in Conshohocken, Pennsylvania, will fulfill the delivery order from its corporate office location, supplying pharmaceutical products and medical supplies to support federal medical procurement needs for military and veteran healthcare systems. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for the Defense Logistics Agency's medical supply chain operations. The company holds a significant $999,999,999.00 IDC with DLA Troop Support Medical (designated SPE2DX) extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. This delivery order falls within that broader contract vehicle and reflects AmerisourceBergen's extensive portfolio of competitively awarded federal contracts encompassing brand-name and generic medications, specialty pharmaceuticals, vaccines, and medical devices across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $122.9k | 12/9/25 |